Boys Arnold & Co. Inc. cut its holdings in Aetna Inc. (NYSE:AET) by 2.1% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 38,890 shares of the company’s stock after selling 840 shares during the quarter. Aetna accounts for approximately 1.0% of Boys Arnold & Co. Inc.’s holdings, making the stock its 24th largest position. Boys Arnold & Co. Inc.’s holdings in Aetna were worth $6,184,000 at the end of the most recent quarter.
A number of other hedge funds have also added to or reduced their stakes in AET. Segall Bryant & Hamill LLC lifted its position in Aetna by 7.8% in the 1st quarter. Segall Bryant & Hamill LLC now owns 2,346 shares of the company’s stock valued at $299,000 after acquiring an additional 170 shares in the last quarter. Teacher Retirement System of Texas lifted its position in Aetna by 6.8% in the 1st quarter. Teacher Retirement System of Texas now owns 262,197 shares of the company’s stock valued at $33,443,000 after acquiring an additional 16,786 shares in the last quarter. Cleararc Capital Inc. lifted its position in Aetna by 0.9% in the 1st quarter. Cleararc Capital Inc. now owns 8,594 shares of the company’s stock valued at $1,096,000 after acquiring an additional 77 shares in the last quarter. Loomis Sayles & Co. L P lifted its position in Aetna by 20.3% in the 1st quarter. Loomis Sayles & Co. L P now owns 430,541 shares of the company’s stock valued at $54,915,000 after acquiring an additional 72,745 shares in the last quarter. Finally, Global X Management Co. LLC lifted its position in Aetna by 39.2% in the 1st quarter. Global X Management Co. LLC now owns 7,259 shares of the company’s stock valued at $926,000 after acquiring an additional 2,045 shares in the last quarter. 89.45% of the stock is currently owned by institutional investors and hedge funds.
In related news, President Karen S. Lynch sold 15,271 shares of the business’s stock in a transaction dated Monday, September 18th. The shares were sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the transaction, the president now directly owns 64,261 shares in the company, valued at $10,404,498.51. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Margaret M. Mccarthy sold 10,288 shares of the business’s stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the transaction, the executive vice president now owns 33,563 shares in the company, valued at $5,465,734.55. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Boys Arnold & Co. Inc. Has $6.18 Million Position in Aetna Inc. (AET)” was posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be accessed at https://www.com-unik.info/2017/10/31/boys-arnold-co-inc-has-6-18-million-position-in-aetna-inc-aet.html.
Shares of Aetna Inc. (NYSE:AET) traded down 0.756% on Tuesday, hitting $169.935. 2,529,093 shares of the company were exchanged. The stock has a market capitalization of $56.44 billion, a PE ratio of 37.721 and a beta of 0.53. Aetna Inc. has a 52-week low of $104.59 and a 52-week high of $184.98. The firm’s 50-day moving average is $159.56 and its 200-day moving average is $151.91.
Aetna (NYSE:AET) last posted its quarterly earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share for the quarter, topping analysts’ consensus estimates of $2.07 by $0.38. The firm had revenue of $14.99 billion for the quarter, compared to analyst estimates of $15.12 billion. Aetna had a net margin of 2.52% and a return on equity of 20.52%. Aetna’s quarterly revenue was down 5.0% on a year-over-year basis. During the same period in the previous year, the business posted $2.07 earnings per share. Equities research analysts predict that Aetna Inc. will post $9.49 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Friday, October 27th. Investors of record on Thursday, October 12th were given a dividend of $0.50 per share. The ex-dividend date was Wednesday, October 11th. This represents a $2.00 dividend on an annualized basis and a yield of 1.17%. Aetna’s payout ratio is presently 43.67%.
A number of equities research analysts have weighed in on the stock. Argus reiterated a “buy” rating and set a $185.00 target price (up from $165.00) on shares of Aetna in a research note on Tuesday, September 12th. BMO Capital Markets boosted their target price on shares of Aetna from $175.00 to $200.00 and gave the company a “market perform” rating in a research note on Friday. BidaskClub lowered shares of Aetna from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 19th. Morgan Stanley boosted their target price on shares of Aetna from $172.00 to $179.00 and gave the company an “overweight” rating in a research note on Thursday, August 17th. Finally, Zacks Investment Research upgraded shares of Aetna from a “hold” rating to a “buy” rating and set a $170.00 target price for the company in a research note on Tuesday, July 4th. Nine analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $163.67.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
What are top analysts saying about Aetna Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Aetna Inc. and related companies.